MD&M West | Anaheim, CA | Feb 3-5 | #4149
DI Labs is excited to be heading back to MD&M West this February! We look forward to connecting with medtech innovation teams with a passion for making an impact. Often, they are surprised to learn that additive manufacturing can be a strategic tool well beyond prototypes, all the way through clinical trials and commercialization. But it must be built into the plan intentionally and early. Today, more than 80% of our work supports production programs for regulated applications, giving us a wealth of experience with medical device programs and teams looking to accelerate their journey and increase their impact on clinical success and positive patient outcomes.
Stop by and talk with our team of engineers and solutionologists to learn more.
MD&M West Technical Session | Feb 3 | 1:15pm
Carl Douglass, P.E., CEO of DI Labs, will also be presenting a technical session at MD&M West designed for program managers, quality and operations leaders, and product development professionals working in regulated medical device environments.
Brief Overview: Additive manufacturing (AM) is a powerful tool for accelerating regulated medical device development—but its value hinges on how and when it’s applied. In this session, we’ll explore the real-world use of polymer AM for producing Class II and III medical device components (excluding implantables), with a focus on accelerating iteration, enabling human feedback, and supporting clinical and commercial success.
I'd like an engineering consult at MD&M West.
"*" indicates required fields